FDA Drug Recalls

Global Pharma Healthcare is issuing a voluntary nationwide recall of all lots within the expiry of their Artificial Tears Lubricant Eye Drops. The consumer-level recall is carried out due to possible contamination of the products distributed by /EzriCare, LLC- and Delsam Pharma. This recall was initiated after the Center for Disease Control and Prevention (CDC) […]

Spectrum Laboratory Products, Inc. has issued a voluntary recall of its Epinephrine (L-Adrenaline) USP Bulk Active Pharmaceutical Ingredient (API), Lot number LP5003, Expiration date 12/2020, due to the product being discolored. The user-level recall was initiated after consumer complaints of the products being discolored. Risk Statement Epinephrine is used to treat critical life-threatening conditions that

GFA Production (Xiamen) Co., Ltd issues a nationwide voluntary recall of Asy Care First Aid Burn Cream and First Aid Kits due to microbial contamination. The consumer-level recall was initiated after FDA testing revealed the presence of Bacillus licheniformis and Bacillus sonorensis in the products. Consumers can identify these products with their 0.9 g single-use

Lupin Pharmaceuticals is issuing a voluntary nationwide recall of four lots of Quinapril tablets due to the potential presence of an N-Nitroso-Quinapril impurity. N-Nitroso-Quinapril is a nitrosamine impurity identified as a probable human carcinogen based on laboratory testing. The recall was initiated after recent testing confirmed that the level of N-Nitroso-Quinapril impurity in the affected

Accord Healthcare Inc. has issued a voluntary nationwide recall of a single lot of Daptomycin for Injection 500 mg/vial and Daptomycin for Injection 350 mg/vial due to a product mix-up. The affected lot # R2200232 was distributed in cartons with an expiry date of 01/2025. The consumer-level recall was initiated after a hospital reported that

Hospira, Inc. has issued a voluntary nationwide recall of one lot of Vancomycin Hydrochloride Injection, USP 1.5g/vial, due to the presence of visible glass particulates observed in multiple vials from one batch. The user level recall affects lot 33045BA, distributed nationwide to wholesalers, distributors, and hospitals throughout the United States and Puerto Rico between June